» Articles » PMID: 31780784

Brain Metastasis

Overview
Journal Nat Rev Cancer
Specialty Oncology
Date 2019 Nov 30
PMID 31780784
Citations 176
Authors
Affiliations
Soon will be listed here.
Abstract

Brain metastasis, which commonly arises in patients with lung cancer, breast cancer and melanoma, is associated with poor survival outcomes and poses distinct clinical challenges. The brain microenvironment, with its unique cell types, anatomical structures, metabolic constraints and immune environment, differs drastically from microenvironments of extracranial lesions, imposing a distinct and profound selective pressure on tumour cells that, in turn, shapes the metastatic process and therapeutic responses. Accordingly, the study of brain metastasis could uncover new therapeutic targets and identify novel treatment approaches to address the unmet clinical need. Moreover, such efforts could provide insight into the biology of primary brain tumours, which face similar challenges to brain metastases of extracranial origin, and vice versa. However, the paucity of robust preclinical models of brain metastasis has severely limited such investigations, underscoring the importance of developing improved experimental models that holistically encompass the metastatic cascade and/or brain microenvironment. In this Viewpoint, we asked four leading experts to provide their opinions on these important aspects of brain metastasis biology and management.

Citing Articles

Confocal Laser Endomicroscopy: Enhancing Intraoperative Decision Making in Neurosurgery.

Carbone F, Fochi N, Di Perna G, Wagner A, Schlegel J, Ranieri E Diagnostics (Basel). 2025; 15(4).

PMID: 40002650 PMC: 11854171. DOI: 10.3390/diagnostics15040499.


The bacterial microbiome modulates the initiation of brain metastasis by impacting the gut-to-brain axis.

Massara M, Ballabio M, Dolfi B, Morad G, Wischnewski V, Lamprou E iScience. 2025; 28(2):111874.

PMID: 39995854 PMC: 11848439. DOI: 10.1016/j.isci.2025.111874.


Research trends on stereotactic radiosurgery in brain metastases: a bibliometric analysis from 2013 to 2023.

Zhong Y, Wang Y, Zhang L, Wen Z, Bao S, Chen S Quant Imaging Med Surg. 2025; 15(2):1297-1311.

PMID: 39995737 PMC: 11847207. DOI: 10.21037/qims-24-1403.


Invasion and metastasis in cancer: molecular insights and therapeutic targets.

Li Y, Liu F, Cai Q, Deng L, OuYang Q, Zhang X Signal Transduct Target Ther. 2025; 10(1):57.

PMID: 39979279 PMC: 11842613. DOI: 10.1038/s41392-025-02148-4.


Clinical characteristics and outcomes of surgical resection for brain metastases from lung adenocarcinoma.

Li M, Li Z, Zhang H, Wakimoto H, Sun L, Wang T Front Oncol. 2025; 14:1453177.

PMID: 39906663 PMC: 11790614. DOI: 10.3389/fonc.2024.1453177.


References
1.
Valiente M, Ahluwalia M, Boire A, Brastianos P, Goldberg S, Lee E . The Evolving Landscape of Brain Metastasis. Trends Cancer. 2018; 4(3):176-196. PMC: 6602095. DOI: 10.1016/j.trecan.2018.01.003. View

2.
Boire A, Zou Y, Shieh J, Macalinao D, Pentsova E, Massague J . Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis. Cell. 2017; 168(6):1101-1113.e13. PMC: 5405733. DOI: 10.1016/j.cell.2017.02.025. View

3.
Neman J, Termini J, Wilczynski S, Vaidehi N, Choy C, Kowolik C . Human breast cancer metastases to the brain display GABAergic properties in the neural niche. Proc Natl Acad Sci U S A. 2014; 111(3):984-9. PMC: 3903266. DOI: 10.1073/pnas.1322098111. View

4.
Berghoff A, Fuchs E, Ricken G, Mlecnik B, Bindea G, Spanberger T . Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases. Oncoimmunology. 2016; 5(1):e1057388. PMC: 4760339. DOI: 10.1080/2162402X.2015.1057388. View

5.
Sevenich L, Bowman R, Mason S, Quail D, Rapaport F, Elie B . Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S. Nat Cell Biol. 2014; 16(9):876-88. PMC: 4249762. DOI: 10.1038/ncb3011. View